SCHEMBL6012619

SCHEMBL6012619

CCCCN1C(=O)C(C(O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(C)C)cc1)CC2

nearest known ligand 0.77

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 20/20 0.77
CYP2C9 P11712 3/20 0.77
CYP2D6 P10635 2/20 0.77
CXCR4 P61073 2/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5343412 1.00 CCR5 (0.77) CCR5CYP2C9CYP2D6CXCR4
Hydrochloric Acid SCHEMBL5346132 0.99 CCR5 (0.77) CCR5CYP2C9CYP2D6CXCR4
Hydrochloric Acid SCHEMBL5611975 0.99 CCR5 (0.77) CCR5CYP2C9CYP2D6CXCR4
Hydrochloric Acid SCHEMBL6188800 0.92 CCR5 (0.79) CCR5CYP2C9CYP2D6CXCR4
SCHEMBL14404708 0.91 CCR5 (0.71) CCR5CYP2C9CYP2D6CXCR4
SCHEMBL5349578 0.91 CCR5 (0.81) CCR5CYP2C9CYP2D6CXCR4
Hydrochloric Acid SCHEMBL6188094 0.91 CCR5 (0.91) CCR5CYP2C9CYP2D6CXCR4
Hydrochloric Acid SCHEMBL6188770 0.91 CCR5 (0.79) CCR5CYP2C9CYP2D6CXCR4
SCHEMBL6188499 0.91 CCR5 (0.86) CCR5CYP2C9CYP2D6CXCR4
SCHEMBL5612435 0.91 CCR5 (0.86) CCR5CYP2C9CYP2D6CXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7119091-B2 Triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising thereof, as an active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2006-10-10 US claimed
EP-1236726-B1 TRIAZASPIRO 5.5]UNDECANE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO (JP) 2004-12-01 EP claimed
EP-1236726-A1 TRIAZASPIRO 5.5]UNDECANE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2002-09-04 EP claimed
EP-1438962-A1 DRUGS COMPRISING COMBINATION OF TRIAZASPIRO 5,5 U NDECANE DERIVATIVE WITH CYTOCHROME P450 ISOZYME 3A4 INHIBITOR AND/OR P−GLYCOPROTEIN INHIBITOR ONO PHARMACEUTICAL CO., LTD. (JP) 2004-07-21 EP disclosed